Animal Blood Plasma Products and Derivatives Market Report – Research, Industry Analysis Reports and Market Demands

Global Animal Blood Plasma Products and Derivatives Market Insights, Forecast to 2025

Request for Sample of this report

Buy now

Table of Content

1 Study Coverage

1.1 Animal Blood Plasma Products and Derivatives Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
- 1.4.1 Global Animal Blood Plasma Products and Derivatives Market Size Growth Rate by Product
- 1.4.2 Immunoglobulin
- 1.4.3 Fibrinogen
- 1.4.4 Serum Albumin
- 1.4.5 Fetal Bovine Serum
1.5 Market by End User
- 1.5.1 Global Animal Blood Plasma Products and Derivatives Market Size Growth Rate by End User
- 1.5.2 Cell Culture Media
- 1.5.3 Food Industry
- 1.5.4 Pharmaceutical Industry
- 1.5.5 Sports Nutrition
- 1.5.6 Nutrition Supplements
- 1.5.7 Cosmetic Industry
- 1.5.8 Diagnostic Industry
- 1.5.9 Pet Food Industry
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global Animal Blood Plasma Products and Derivatives Market Size
- 2.1.1 Global Animal Blood Plasma Products and Derivatives Revenue 2014-2025
- 2.1.2 Global Animal Blood Plasma Products and Derivatives Sales 2014-2025
2.2 Animal Blood Plasma Products and Derivatives Growth Rate by Regions
- 2.2.1 Global Animal Blood Plasma Products and Derivatives Sales by Regions
- 2.2.2 Global Animal Blood Plasma Products and Derivatives Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Animal Blood Plasma Products and Derivatives Sales by Manufacturers
- 3.1.1 Animal Blood Plasma Products and Derivatives Sales by Manufacturers
- 3.1.2 Animal Blood Plasma Products and Derivatives Sales Market Share by Manufacturers
- 3.1.3 Global Animal Blood Plasma Products and Derivatives Market Concentration Ratio (CR5 and HHI)
3.2 Animal Blood Plasma Products and Derivatives Revenue by Manufacturers
- 3.2.1 Animal Blood Plasma Products and Derivatives Revenue by Manufacturers (2014-2019)
- 3.2.2 Animal Blood Plasma Products and Derivatives Revenue Share by Manufacturers (2014-2019)
3.3 Animal Blood Plasma Products and Derivatives Price by Manufacturers
3.4 Animal Blood Plasma Products and Derivatives Manufacturing Base Distribution, Product Types
- 3.4.1 Animal Blood Plasma Products and Derivatives Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Animal Blood Plasma Products and Derivatives Product Type
- 3.4.3 Date of International Manufacturers Enter into Animal Blood Plasma Products and Derivatives Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Animal Blood Plasma Products and Derivatives Sales by Product
4.2 Global Animal Blood Plasma Products and Derivatives Revenue by Product
4.3 Animal Blood Plasma Products and Derivatives Price by Product

5 Breakdown Data by End User

5.1 Overview
5.2 Global Animal Blood Plasma Products and Derivatives Breakdown Data by End User

6 North America

6.1 North America Animal Blood Plasma Products and Derivatives by Countries
- 6.1.1 North America Animal Blood Plasma Products and Derivatives Sales by Countries
- 6.1.2 North America Animal Blood Plasma Products and Derivatives Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
6.2 North America Animal Blood Plasma Products and Derivatives by Product
6.3 North America Animal Blood Plasma Products and Derivatives by End User

7 Europe

7.1 Europe Animal Blood Plasma Products and Derivatives by Countries
- 7.1.1 Europe Animal Blood Plasma Products and Derivatives Sales by Countries
- 7.1.2 Europe Animal Blood Plasma Products and Derivatives Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
7.2 Europe Animal Blood Plasma Products and Derivatives by Product
7.3 Europe Animal Blood Plasma Products and Derivatives by End User

8 Asia Pacific

8.1 Asia Pacific Animal Blood Plasma Products and Derivatives by Countries
- 8.1.1 Asia Pacific Animal Blood Plasma Products and Derivatives Sales by Countries
- 8.1.2 Asia Pacific Animal Blood Plasma Products and Derivatives Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
8.2 Asia Pacific Animal Blood Plasma Products and Derivatives by Product
8.3 Asia Pacific Animal Blood Plasma Products and Derivatives by End User

9 Central & South America

9.1 Central & South America Animal Blood Plasma Products and Derivatives by Countries
- 9.1.1 Central & South America Animal Blood Plasma Products and Derivatives Sales by Countries
- 9.1.2 Central & South America Animal Blood Plasma Products and Derivatives Revenue by Countries
- 9.1.3 Brazil
9.2 Central & South America Animal Blood Plasma Products and Derivatives by Product
9.3 Central & South America Animal Blood Plasma Products and Derivatives by End User

10 Middle East and Africa

10.1 Middle East and Africa Animal Blood Plasma Products and Derivatives by Countries
- 10.1.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Countries
- 10.1.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
10.2 Middle East and Africa Animal Blood Plasma Products and Derivatives by Product
10.3 Middle East and Africa Animal Blood Plasma Products and Derivatives by End User

11 Company Profiles

12 Future Forecast

12.1 Animal Blood Plasma Products and Derivatives Market Forecast by Regions
- 12.1.1 Global Animal Blood Plasma Products and Derivatives Sales Forecast by Regions 2019-2025
- 12.1.2 Global Animal Blood Plasma Products and Derivatives Revenue Forecast by Regions 2019-2025
12.2 Animal Blood Plasma Products and Derivatives Market Forecast by Product
- 12.2.1 Global Animal Blood Plasma Products and Derivatives Sales Forecast by Product 2019-2025
- 12.2.2 Global Animal Blood Plasma Products and Derivatives Revenue Forecast by Product 2019-2025
12.3 Animal Blood Plasma Products and Derivatives Market Forecast by End User
12.4 North America Animal Blood Plasma Products and Derivatives Forecast
12.5 Europe Animal Blood Plasma Products and Derivatives Forecast
12.6 Asia Pacific Animal Blood Plasma Products and Derivatives Forecast
12.7 Central & South America Animal Blood Plasma Products and Derivatives Forecast
12.8 Middle East and Africa Animal Blood Plasma Products and Derivatives Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis
14.2 Animal Blood Plasma Products and Derivatives Customers
14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
16.2 Author Details

Description

Animal blood is one of the main by-products of animal slaughtering and processing. It has rich protein content and high nutritional value. Plasma protein, as an important protein material, can be used for animal feed and food processing. Studies have shown that plasma proteins are enzymatically treated to obtain hydrolysates consisting of small peptides and amino acids, which are more easily digested and absorbed by the body. At the same time, they show antioxidant properties, inhibition of angiotensin converting enzyme activity, attenuation, and other functional properties and can be used as potential nutrients. Supplements, food additives, and nutraceuticals.
Plasma protein is the most important solid component in plasma, and its amino acid content is rich and its nutritional value is high. At present, it is mainly processed into plasma protein powder as livestock feed or nutritional supplement, or as a raw material or additive for various food systems [11]. Studies have shown that plasma proteins are hydrolyzed by specific enzymes to produce hydrolysates consisting of small peptides and amino acids, which are more easily digested and absorbed by the human body. At the same time, they show antioxidation, inhibition of angiotensin-converting enzyme (ACE) and attenuation. The functional properties of peptides isolated from them have been widely studied as potential nutritional supplements, food additives and nutraceuticals.
The global Animal Blood Plasma Products and Derivatives market is valued at 1030 million US$ in 2018 and will reach 1880 million US$ by the end of 2025, growing at a CAGR of 7.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Animal Blood Plasma Products and Derivatives market based on company, product type, end user and key regions.

This report studies the global market size of Animal Blood Plasma Products and Derivatives in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Animal Blood Plasma Products and Derivatives in these regions.
This research report categorizes the global Animal Blood Plasma Products and Derivatives market by top players/brands, region, type and end user. This report also studies the global Animal Blood Plasma Products and Derivatives market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Lake Immunogenics
Auckland BioSciences
Kraeber & Co. GmbH
Sigma-Aldrich
Thermo Fisher Scientific
Rocky Mountain Biologicals
LAMPIRE Biological Laboratories
Bovogen Biologicals
Proliant
ANZCO Foods

Market size by Product
Immunoglobulin
Fibrinogen
Serum Albumin
Fetal Bovine Serum
Market size by End User
Cell Culture Media
Food Industry
Pharmaceutical Industry
Sports Nutrition
Nutrition Supplements
Cosmetic Industry
Diagnostic Industry
Pet Food Industry

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Animal Blood Plasma Products and Derivatives market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Animal Blood Plasma Products and Derivatives market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Animal Blood Plasma Products and Derivatives companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Animal Blood Plasma Products and Derivatives submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Animal Blood Plasma Products and Derivatives are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Animal Blood Plasma Products and Derivatives market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.